LeMaitre Vascular (NasdaqGM:LMAT) Q4 2025 Earnings call February 25, 2026 05:00 PM ET Company ParticipantsDanny Stauder - Director of Equity ResearchDave Roberts - PresidentDorian LeBlanc - CFOGeorge LeMaitre - CEORick Wise - Managing DirectorConference Call ParticipantsBrett Fishbin - VP and Senior Equity Research AnalystJim Sidoti - AnalystKyle Bauser - Managing Director and Senior Research AnalystMichael Petusky - Managing Director and Senior Investment AnalystMichael Sarcone - Equity AnalystNone - Analy ...

LeMaitre Vascular (NasdaqGM:LMAT) Q4 2025 Earnings call February 25, 2026 05:00 PM ET Company ParticipantsDanny Stauder - Director of Equity ResearchDave Roberts - PresidentDorian LeBlanc - CFOGeorge LeMaitre - CEORick Wise - Managing DirectorConference Call ParticipantsBrett Fishbin - VP and Senior Equity Research AnalystJim Sidoti - AnalystKyle Bauser - Managing Director and Senior Research AnalystMichael Petusky - Managing Director and Senior Investment AnalystMichael Sarcone - Equity AnalystNone - Analy ...

LeMaitre Vascular (NasdaqGM:LMAT) Q4 2025 Earnings call February 25, 2026 05:00 PM ET Speaker8Welcome to the LeMaitre Vascular Q4 2025 financial results conference call. As a reminder, today's call is being recorded. At this time, I would like to turn the call over to Mr. Dorian LeBlanc, the Chief Financial Officer of LeMaitre Vascular. Please go ahead, sir.Speaker2Thank you. Good afternoon, and thank you for joining us on our Q4 2025 conference call. With me on today's call is our CEO, George LeMaitre, and ...